Skip to content
Third-party HPLC + mass spec on every lot
Verified — all release criteria met
releasedCurrent lot

Certificate of analysis

Hexarelin

Lot CP-HEXAREJB-2607A · 5 mg

98.77 %

HPLC purity

Spec ≥ 98.0 %

88.0 %

Net peptide content

By amino acid analysis

< 0.44

Endotoxin (EU/mg)

Spec < 5.0 EU/mg

Provenance

Testing laboratory
Janoshik Analytical
Accreditation
ISO/IEC 17025:2017
Country of synthesis
United States
Manufactured
Jun 29, 2026
Release tested
Jul 8, 2026 (3 months ago)
Retest date
Jun 28, 2028
CAS number
140703-51-1
Molecular formula
C47H58N12O6
Theoretical mass
887.03 Da
Observed mass (LC-MS)
886.99 Da (Δ 0.04 Da)

Assay results

Every line the release panel ran for this lot, with the method, the acceptance criterion and the measured value — not a pass mark alone.

Certificate of analysis — assay results
MethodParameterSpecificationResult
RP-HPLC (UV 214 nm)Purity (area %)≥ 98.0 %98.77 %Pass
LC-MS (ESI+)Identity — observed mass887.03 ± 1.0 Da886.99 DaPass
Amino acid analysisNet peptide content≥ 80.0 %88.0 %Pass
Karl FischerWater content≤ 8.0 %3.30 %Pass
Ion chromatographyResidual TFA≤ 1.0 %0.22 %Pass
LAL kinetic chromogenicBacterial endotoxin< 5.0 EU/mg< 0.44 EU/mgPass
USP <71> membrane filtrationSterilityNo growthNo growthPass
Visual / USP <790>AppearanceWhite to off-white cake, free of visible particulatesConformsPass

Sequence

H-His-D-2-methyl-Trp-Ala-Trp-D-Phe-Lys-NH2

Handling for this lot

Appearance
White lyophilised powder
Storage
-20 °C lyophilised, protected from light
Reconstitution
Protect reconstituted solutions from light — the two tryptophan residues photo-oxidise.

Other lots of Hexarelin

Compare batch to batch. Consistency across lots is a stronger signal than any single certificate.

Research use only. This certificate describes material supplied strictly for laboratory research. It is not a drug, food, cosmetic or medical device, has not been evaluated by the FDA, and is not intended for human or veterinary administration of any kind.